Tatsuhiro Ishida

15.8k citations

282 papers · 12.8k indexed · 4 hit papers · h-index 58

Impact in

Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems

Papers in

Biomaterials 94
- Nanoparticle-Based Drug Delivery 92
Pharmaceutical Science 21
- Advanced Drug Delivery Systems 17

Co-authors: Hiroshi Kiwada Amr S. Abu Lila Taro Shimizu Masako Ichihara Xinyu Wang Hideyoshi Harashima Yu Ishima János Szebeni
Journals: Biological and Pharmaceutical Bulletin (37 papers)Journal of Controlled Release (37 papers)International Journal of Pharmaceutics (37 papers)Pharmaceutical Research (8 papers)Journal of Pharmaceutical Sciences (6 papers)
Partner nations: Japan Egypt Saudi Arabia

In The Last Decade

Tatsuhiro Ishida

276 papers receiving 12.6k citations

Hit Papers

align trajectories log scale

Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products 2022 · 286 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Journal of Controlled Release
2020 Advanced Drug Delivery Reviews
2019 Science and Technology of Advanced Materials
2013 Journal of Controlled Release

Peers

Countries citing papers authored by Tatsuhiro Ishida

Since Specialization

Citations

This map shows the geographic impact of Tatsuhiro Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuhiro Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuhiro Ishida more than expected).

Fields of papers citing papers by Tatsuhiro Ishida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuhiro Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuhiro Ishida. The network helps show where Tatsuhiro Ishida may publish in the future.

Co-authors

The 25 scholars most cited alongside Tatsuhiro Ishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tatsuhiro Ishida Line = papers co-authored together Tatsuhiro Ishida links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes Biological and Pharmaceutical Bulletin ·Taro Shimizu, Amr S. Abu Lila, S. Chauhan, Ryo Abe, V.I. Galkin, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida	2024	2
2	Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways Pharmaceuticals ·Mayumi Ikeda, Tatsuya Fukuta, Victor Tuan Giam Chuang, Tomohiro Sawa, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida, Yu Ishima	2024	3
3	Application of bacterial-derived long cellulose nanofiber to suspension culture of mammalian cells as a shear protectant International Journal of Biological Macromolecules ·Dennis Kelly, 童群义, Masashi Fujiwara, Hidenori Ando, Yasushi Sato, Tatsuhiro Ishida, Hirofumi Tani, Kenji Tajima	2024	1
4	Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route Journal of Controlled Release ·V.I. Galkin, Taro Shimizu, Michael Stöckl, Nehal E. Elsadek, Sherif E. Emam, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida	2023	22
5	A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrest European Journal of Pharmacology ·Hidenori Ando, Kiyoshi Eshima, Tatsuhiro Ishida	2023	1
6	Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives Journal of Pharmaceutical Sciences ·Anand Sambhaw, Taro Shimizu, Hidenori Ando, V.I. Galkin, Sherif E. Emam, Eslam Ramadan, Youssef W. Naguib, Fatma M. Mady, Khaled A. Khaled, Tatsuhiro Ishida	2023	24
7	The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors Pharmaceutics ·Ryo Kinoshita, Yu Ishima, Victor Tuan Giam Chuang, Hiroshi Watanabe, Taro Shimizu, Hidenori Ando, Keiichiro Okuhira, Masaki Otagiri, Tatsuhiro Ishida, Toru Maruyama	2021	8
8	Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection Nanomaterials ·Hidenori Ando, Veronica Richina, Amr S. Abu Lila, Esin Ekizoglu, Kenji Tajima, Kenji Fujita, Taro Shimizu, Yu Ishima, W.M. Houlker, Yuta Komiya, Tatsuhiro Ishida	2021	10
9	Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice Pharmaceutics ·Wang Mei-rong, Taro Shimizu, Amr S. Abu Lila, Yuki Kanazawa, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida	2020	8
10	A Unique Gene-Silencing Approach, Using an Intelligent RNA Expression Device (iRed), Results in Minimal Immune Stimulation When Given by Local Intrapleural Injection in Malignant Pleural Mesothelioma Molecules ·Hidenori Ando, 樊培樑, Amr S. Abu Lila, J. L. Castel, Taro Shimizu, Yu Ishima, Noriaki Minakawa, Tatsuhiro Ishida	2020	2
11	Blood retention and antigenicity of polycarboxybetaine-modified liposomes International Journal of Pharmaceutics ·José Octavio Salcedo Parra, Taro Shimizu, Ryo Miyahara, Daisuke Asai, 純雲井, Takuma Yoshikawa, Akihiro Kishimura, Takeshi Mori, Tatsuhiro Ishida, Yoshiki Katayama	2020	14
12	Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities Molecules ·Mayumi Ikeda, Yu Ishima, Victor Tuan Giam Chuang, Yu Konno, Jan Wüster, Hidenori Ando, Taro Shimizu, Keiichiro Okuhira, Hiroshi Watanabe, Toru Maruyama, Masaki Otagiri, Takaaki Akaike, Tatsuhiro Ishida	2019	21
13	Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape Journal of Controlled Release ·Indu Chandran, Hiroshi Watanabe, Hitoshi Maeda, Keisuke Hamasaki, Assunta Bizzarro, Victor Tuan Giam Chuang, Ryo Kinoshita, Kento Nishida, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Takahiro Seki, Hiroshi Katsuki, Shiroh Futaki, Masaki Otagiri, Toru Maruyama	2019	23
14	Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization International Journal of Nanomedicine ·Tamás Mészáros, Gergely Tibor Kozma, Taro Shimizu, Autran José da, Keren Turjeman, Tatsuhiro Ishida, Yechezkel Barenholz, Rudolf Urbanics, János Szebeni	2018	27
15	A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes The Journal of Immunology ·Taro Shimizu, Amr S. Abu Lila, Amnah Bayani, 鹿野満, Yuki Watanabe, Jiaxu He, Yosuke Hashimoto, Keiichiro Okuhira, Gert Storm, Yu Ishima, Tatsuhiro Ishida	2018	27
16	Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways Scientific Reports ·Sherif E. Emam, Hidenori Ando, Amr S. Abu Lila, Taro Shimizu, Keiichiro Okuhira, Yu Ishima, Mahmoud A. Mahdy, Rohini Honap, Martínez López-Cano, Tatsuhiro Ishida	2018	35
17	Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity Journal of Controlled Release ·Jiaxu He, Amr S. Abu Lila, Taro Shimizu, Masami Ukawa, Hidenori Ando, Ian M. Smith, Tatsuhiro Ishida	2017	47
18	Accelerated blood clearance of PEGylated liposomes after repeated injection Drug Delivery System ·Tatsuhiro Ishida, Hiroshi Kiwada	2004	8
19	Effect of liposome sizes on binding of C3 fragments to cetylmannoside-modified liposomes in human. Drug Delivery System ·Tatsuhiro Ishida, Xuefei CHEN, Hiroshi Kiwada	1997	1
20	Quantitative determination of C3 fragments on the liposomal surface with anti-human C3 monoclonal antibodies. Drug Delivery System ·Tatsuhiro Ishida, Xuefei CHEN, Luke J. Bonanni, Yasukazu Ohmoto, Hiroshi Kiwada	1994	2

About Tatsuhiro Ishida

Tatsuhiro Ishida is a scholar working on Biomaterials, Pharmaceutical Science, Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 282 papers that have together received 12.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (96 papers), Nanoparticle-Based Drug Delivery (92 papers), Immunotherapy and Immune Responses (48 papers), Monoclonal and Polyclonal Antibodies Research (30 papers), Advanced biosensing and bioanalysis techniques (26 papers), Nanoplatforms for cancer theranostics (25 papers), Advanced Drug Delivery Systems (17 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Biomaterials (5.5k citations), Pharmaceutical Science (1.5k citations), Immunology (2.2k citations), Molecular Biology (6.9k citations) and Biomedical Engineering (2.7k citations). Tatsuhiro Ishida has collaborated with scholars based in Japan, Egypt and Saudi Arabia. Frequent co-authors include Hiroshi Kiwada, Amr S. Abu Lila, Taro Shimizu, Masako Ichihara, Xinyu Wang, Hideyoshi Harashima, Yu Ishima, János Szebeni, Hidenori Ando and Kenji Irimura. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Controlled Release, International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact